Catalyst

Slingshot members are tracking this event:

FDA PDUFA date for IntelliPharmaCeutics (IPCI) Rexista, an abuse-deterrent of oxycodone, set for September 25th

Source Link:
https://seekingalpha.com/news/3240326-fda-review-intellipharmaceutics-nda-abuse-deterrent-oxycodone-shares-ahead-10-percent-hours

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
IPCI Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Sept 25: FDA rejected Rexista in its current form.
http://www.intelliph...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 25, 2017
Occurred Source:
http://www.intellipharmaceutics.com/releasedetail.cfm?ReleaseID=1041478
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Oxycodone, Pdufa Date, Rexista
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.